Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

GLV-B GLV-A NRG BQE Real Estate Government Software GBP Bitcoins 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Processing. Please wait...

Epicore insider: Fred Boulos

       

Fred Boulos - Epicore Insider Profile

Independent Director

Mr. Fred N. Boulos is Independent Director of Epicore Bionetworks Inc., since March 12, 2007. He is Principal, FNB Consulting Inc., a management consulting firm, 2003 to present; Contracts Manager, Alsthom Cegelec, Bouygues France & KBR J.V., a Chad/Cameroon Oil Exploration and Pipeline Project, 2001 to 2003. He has over 30 years of business experience.
  Director Since 2007      

Other Appointments

EPCBFEPCBFUnited States OTC
Director since 2007
Epicore BioNetworks IncEPCBFUnited States OTC
Director since 2007

Management Efficency

The company has return on total asset (ROA) of 10.25 % which means that it generated profit of $10.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.52 % meaning that it generated $10.52 on every $100 dollars invested by stockholders.
The company has accumulated 498.1 K in total debt with debt to equity ratio (D/E) of 0.1 which may suggest the company is not taking enough advantage from borrowing. Epicore BioNetworks Inc has Current Ratio of 11.75 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
    

Other Executives

Entity Summary

Epicore BioNetworks Inc. designs, develops, and manufactures biotechnology solutions and specialty animal feeds worldwide. Epicore BioNetworks Inc [EBN] is traded on TSX Venture Exchange in Canada. It is located in Eastampton, NJ and employs 8 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
EBN Canada TSXV #2623847CA
Epicore BioNetworks Inc
Benchmark S&P 500
Currency: CAD - Canadian Dollar
Traded on TSX Venture Exchange
    
    
Chance of
Bankruptcy
Less
Than
8%
In The Next
Two Years
Epicore BioNetworks Inc has less than 8.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Epicore price boundaries

    
June 10 2013
 0.16 
  
 0.16 
0.00  No Change   0.00%  
Lowest period price (30 days)
May 21 2013
 0.25 
  
 0.25 
0.00  No Change   0.00%  
Highest period price (30 days)
    

Promote Epicore and Fred Boulos

Follow Epicore with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Epicore to your reader
 

Today Change

 thisGreen EBN EBN.V agains markets  21.87 % Macroaxis: change 21.87 Moved Up  
 
 United States SP 500   0.78 % Macroaxis: 0.78 Moved Up  
 
 Canada Canada   0.64 % Macroaxis: 0.64 Moved Up  
 

Stock Performance

Shares Outstanding24.56 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium